Literature DB >> 15210073

Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.

Zheng-hong Wu1, Qi-neng Ping, Yi Wei, Jia-ming Lai.   

Abstract

AIM: To evaluate the hypoglycemic efficacy of insulin liposomes coated by chitosan with different molecular weights and concentrations after oral administration in mice.
METHODS: Insulin-liposomes were prepared by reversed-phase evaporation. Chitosan coating was carried out by incubation of the liposomal suspensions with the chitosan solution. The hypoglycemic efficacies of chitosan-coated insulin liposomes were investigated by monitoring the blood glucose level using the glucose oxidase method after oral administration to healthy mice.
RESULTS: In all the insulin liposomes, the insulin liposomes coated by 0.2% chitosan (Mr 1000 kDa) showed a better hypoglycemic efficacy as compared with the other liposomes coated by chitosan. The minimum blood glucose level was 15.1%+/-6.0 % of the initial (n=6). The hypoglycemic efficacy lasted for 4 h after oral administration to mice.
CONCLUSION: Chitosan-coated liposomes could reduce tryptic digestion on insulin, and enhance enteral absorption of insulin. The molecular weights and concentrations of chitosan had significant effects on hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration to healthy mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210073

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  8 in total

Review 1.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

Review 2.  Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review.

Authors:  Zeinab Nouri; Marziyeh Hajialyani; Zhila Izadi; Roodabeh Bahramsoltani; Mohammad Hosein Farzaei; Mohammad Abdollahi
Journal:  Front Bioeng Biotechnol       Date:  2020-05-14

Review 3.  Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles.

Authors:  Akhand Pratap Singh; Arpan Biswas; Aparna Shukla; Pralay Maiti
Journal:  Signal Transduct Target Ther       Date:  2019-08-30

Review 4.  Polymer-Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies.

Authors:  Sabrina Bochicchio; Gaetano Lamberti; Anna Angela Barba
Journal:  Pharmaceutics       Date:  2021-02-02       Impact factor: 6.321

5.  Chitosan-covered liposomes as a promising drug transporter: nanoscale investigations.

Authors:  Lemaalem Mohammed; Hadrioui Nourddine; El Fassi Saad; Derouiche Abdelali; Ridouane Hamid
Journal:  RSC Adv       Date:  2021-01-05       Impact factor: 3.361

Review 6.  Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue.

Authors:  Roxana-Maria Amarandi; Alina Ibanescu; Eugen Carasevici; Luminita Marin; Brindusa Dragoi
Journal:  Pharmaceutics       Date:  2022-01-27       Impact factor: 6.321

7.  Pharmacokinetic study of niosome-loaded insulin in diabetic rats.

Authors:  A Pardakhty; E Moazeni; J Varshosaz; V Hajhashemi; A Rouholamini Najafabadi
Journal:  Daru       Date:  2011       Impact factor: 3.117

Review 8.  Nanoparticle Delivery Systems in the Treatment of Diabetes Complications.

Authors:  Eliana B Souto; Selma B Souto; Joana R Campos; Patricia Severino; Tatiana N Pashirova; Lucia Y Zakharova; Amélia M Silva; Alessandra Durazzo; Massimo Lucarini; Angelo A Izzo; Antonello Santini
Journal:  Molecules       Date:  2019-11-20       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.